Idebenone

CHEMBL252556 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
338.4 g/mol
LogP
4.3
Phase
4

A synthetic coenzyme Q10 analogue used for rare mitochondrial diseases.

Molekularmasse

338,4000 g/mol

LogP

4,30

TPSA

72,80 Ų

Lipinski-Regel der Fünf

Bestanden

Therapeutische Bereiche

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O

InChI

InChI=1S/C19H30O5/c1-14-15(12-10-8-6-4-5-7-9-11-13-20)17(22)19(24-3)18(23-2)16(14)21/h20H,4-13H2,1-3H3

Molecular Formula

C19H30O5

HBD / HBA

1 / 5

Rotierbare Bindungen

12

Schwere Atome

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

A synthetic coenzyme Q10 analogue used for rare mitochondrial diseases.

Yes, Idebenone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL252556. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3686. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.